Pharmacoeconomic comparison of ziprasidone with other atypical oral antipsychotic agents in schizophrenia

Objective: to comparatively investigate – by means of computer simulations – the economic cost and clinical outcomes of five atypical oral antipsychotic agents (ziprasidone, olanzapina, risperidone, paliperidone and aripiprazolo). Methods: a cyclical stochastic model representing patient evolution,...

Full description

Bibliographic Details
Main Authors: Andrea Fagiolini, Alice Matone, Claudio Gaz, Simona Panunzi, Andrea De Gaetano
Format: Article
Language:English
Published: SEEd Medical Publishers 2011-11-01
Series:Farmeconomia: Health Economics and Therapeutic Pathways
Subjects:
Online Access:https://journals.seedmedicalpublishers.com/index.php/FE/article/view/96